30

Bioinformatics of the Brain

[47] A. U. Khan, M. Akram, M. Daniyal, et al., “Awareness and current

knowledge of parkinson’s disease: a neurodegenerative disorder,” Inter-

national Journal of Neuroscience, vol. 129, pp. 55–93, 2018.

[48] M. Rodríguez‐Violante, A. Cervantes-Arriaga, S. Fahn, et al., “Two-

hundred years later: Is parkinson’s disease a single defined entity?,”

Revista de investigacion clinica; organo del Hospital de Enfermedades

de la Nutricion, vol. 69 6, pp. 308–313, 2017.

[49] L. de Lau, P. C. Giesbergen, M. C. de Rijk, et al., “Incidence of

parkinsonism and parkinson disease in a general population,” Neurology,

vol. 63, pp. 1240–1244, 2004.

[50] E. R. Dorsey, R. Constantinescu, R. Constantinescu, et al., “Projected

number of people with parkinson disease in the most populous nations,

2005 through 2030,” Neurology, vol. 68, pp. 384–386, 2007.

[51] C. W. Olanow, J. H. Kordower, A. E. Lang, et al., “Dopaminergic trans-

plantation for parkinson’s disease: Current status and future prospects,”

Annals of Neurology, vol. 66, 2009.

[52] J. Tran, H. Anastacio, and C. Bardy, “Genetic predispositions of parkin-

son’s disease revealed in patient-derived brain cells,” NPJ Parkinson’s

Disease, vol. 6, 2020.

[53] C. Blauwendraat, M. A. Nalls, and A. B. Singleton, “The genetic archi-

tecture of parkinson’s disease,” The Lancet Neurology, vol. 19, pp. 170–

178, 2020.

[54] L. V. Kalia, S. K. Kalia, and A. E. Lang, “Disease‐modifying strategies

for parkinson’s disease,” Movement Disorders, vol. 30, 2015.

[55] J. Jankovic, “Parkinson’s disease: Clinical features and diagnosis,”

J Neurol Neurosurg Psychiatry, vol. 79, pp. 368–376, 2008.

[56] J. M. Miyasaki, W. R. W. Martin, O. Suchowersky, et al., “Practice

parameter: Initiation of treatment for parkinson’s disease: An evidence-

based review,” Neurology, vol. 58, pp. 11–17, 2002.

[57] E. Tolosa, A. Garrido, S. W. Scholz, et al., “Challenges in the diagnosis

of parkinson’s disease,” The Lancet Neurology, vol. 20, pp. 385–397,

2021.

[58] N. R. McFarland, “Diagnostic approach to atypical parkinsonian syn-

dromes,” CONTINUUM: Lifelong Learning in Neurology, vol. 22,

p. 1117–1142, 2016.

[59] C. Váradi, “Clinical features of parkinson’s disease: The evolution of

critical symptoms,” Biology, vol. 9, 2020.